Cite
APA Citation
Gonçalves, J., Myung, G., Hong, E., Park, M., Jeong, D., & Ghil, J. (n.d.). p664 SB5 and reference adalimumab show cross-immunogenicity in patients with inflammatory bowel disease or rheumatoid arthritis. Journal of Crohn's and colitis, 13, S451–S452. http://access.bl.uk/ark:/81055/vdc_100094046421.0x00000d